Meet CEO Adar Poonawalla's Wife Natasha, Who Lives in Rs 750 Cr Lincoln House
May 06, 2024, 16:34 PM IST
Cyrus Poonawalla: The Son Of A Horse Breeder Who Didn't Follow His Family's Footsteps But Carved His Own Path And Now Has A Net Worth Of Rs 2,25,000 Crore
Cyrus Poonawalla founded the Serum Institute of India (SII) in 1966, which is today the world's largest vaccine manufacturer.
Jul 16, 2023, 13:04 PM IST
Adar Poonawallah's IMPORTANT MESSAGE amid Covid outbreak in China
Amid an alarming surge of Covid-19 cases in China, the CEO and founder of Serum Institute of India Adar Ponawalla in a tweet has urged the people not to panic. Serum Institute of India is the one who made Covishield covid vaccine.
Dec 21, 2022, 19:59 PM IST
Rising Covid-19 cases in China 'concerning': Serum Institute CEO Adar Poonawalla
We must continue to trust and follow the guidelines set by the Government of India, Serum Institute of India (SII) CEO Adar Poonawalla said as he expressed concern over reports of a rising COVID-19 graph in China.
Dec 21, 2022, 14:51 PM IST
People fed up of Covid-19 pandemic, no takers for booster jabs: SII CEO Adar Poonawalla
"Since December 2021, we have stopped the production of the Covishield vaccine. We had a stock of a few hundred million doses at that time and of that 100 million doses had already expired," Poonawalla said.
Oct 21, 2022, 09:02 AM IST
Fraudsters dupe Serum Institute of over Rs 1 crore by asking for money in CEO Adar Poonawalla's name
One of the directors of the SII received WhatsApp messages from a person who posed as Adar Poonawalla. The sender asked him to transfer money to certain bank accounts immediately. Believing that it was the CEO who had messaged, the company officials transferred Rs 1.01 crore.
Sep 11, 2022, 09:10 AM IST
Man demands Rs 1,000 crore from Covid-19 vaccine makers for daughter's death; Bombay HC issues notice to SII, Bill Gates, others
The petitioner claimed that his daughter, a medical student, was compelled to take the Covid-19 vaccine at her college in Nashik in January as she was a health worker.
Sep 03, 2022, 09:44 AM IST
Government panel recommends emergency approval of Serum Institute’s Covovax for 7-11 year age group
"The Subject Expert Committee of Drugs Controller General Of India (DCGI) has recommended Serum Institute of India`s (SII) vaccine Covovax for children in the age group of 7-11 years," sources said.
Jun 25, 2022, 09:10 AM IST
'Never been a better time to be vaccine manufacturer': Serum Institute planning to set up its 1st plant in Africa
Asked about concerns over the rise of monkeypox cases, Serum Institute of India Chief Executive Adar Poonawalla said he believed the "disease was not so infectious", Reuters reported.
May 24, 2022, 12:15 PM IST
India’s Covid-19 vaccine Covovax available for everyone above age of 12 years: Serum Institute CEO Adar Poonawalla
"A lot of you have asked if Covovax is available for adults. The answer is yes, it is available for everyone above the age of 12," Poonawalla tweeted.
May 05, 2022, 08:32 AM IST
Covovax gets recommendation from government panel, to be available for vaccination of kids in 12-17 age group
The Covid-19 Working Group has now recommended to the NTAGI`s Standing Technical Sub Committee that Covovax be included in the national vaccination programme for those aged 12 years and above, sources said.
Apr 04, 2022, 07:29 AM IST
CDSCO panel recommends emergency use authorisation for Covovax, Corbevax
"The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) reviewed the emergency use authorisation (EUA) application for the second time on Monday and after detailed deliberation recommended granting emergency use authorisation to Covovax and COREBEVAX," an official source said.
Dec 27, 2021, 23:47 PM IST
WHO approves Serum Institute's COVID vaccine, Covovax
Covovax is a COVID-19 vaccine made by the Serum Institute of India in collaboration with the US-based Novavax.
Dec 17, 2021, 20:54 PM IST
SII seeks approval for Covishield vaccine as booster dose amid Omicron variant concerns
SII sought approval for the Covishield vaccine as a booster dose citing adequate stock of the vaccine is available in the country.
Dec 02, 2021, 10:47 AM IST
Third jab soon? Serum Institute asks DCGI to allow Covishield as booster dose
SII cited adequate stock of the vaccine in the country and a demand for a booster.
Dec 01, 2021, 21:20 PM IST
World's largest vaccine maker Serum Institute resumes Covishield export to COVAX
Serum Institute has resumed the export of its COVID-19 vaccine 'Covishield' after eight months of hiatus.
Nov 26, 2021, 19:06 PM IST
SII requests Centre to fast-track movement of increasing Covishield stock
Prakash Kumar Singh, Director, Government and Regulatory Affairs at SII, is learnt to have recently communicated to the Union Health Ministry that it has a manufactured stock of 24,89,15,000 Covishield doses and it is increasing every day.
Nov 21, 2021, 20:09 PM IST
As Moderna readies to make an entry into India, list of other COVID-19 vaccine options available
Prime Minister Narendra Modi, has hinted that the supply of COVID-19 vaccines is about to increase in the coming days.
Jul 03, 2021, 23:42 PM IST
British PM Boris Johnson says Covishield shot should be accepted in vaccine passport schemes
About 5 million people in Britain are thought to have had the vaccine made by Serum Institute in India, known as Covishield.
Jul 02, 2021, 19:53 PM IST
'Complete trial on adults first': Government panel says no to Covovax trial by Serum Institute of India
The SII has applied to the Drugs Controller General of India (DCGI) on Monday seeking permission for conducting a trial of Covovax on 920 children, 460 each in the 12-17 and 2-11 age groups, at 10 sites.
Jul 01, 2021, 09:33 AM IST
